The Montreal Clinical Research Institute (IRCM) is proud to announce that Dr. Yasaman Aghazadeh, a Director, Research Unit in Regenerative Medicine for Diabetes at IRCM, has been awarded $350,000 in funding through a Stem Cell Network (SCN) initiative.
As Lead Investigator, Dr. Aghazadeh will lead a project that aims at developing stem cell derived beta cells as a long-term treatment of type 1 diabetes, with potential to reduce or eliminate insulin injections.
With a PhD in experimental medicine from McGill University, she has been working on the regeneration of pancreatic tissue from stem cells for almost ten years.
This funding highlights the excellence of her research and its potential to advance innovative treatments for type 1 diabetes.
Congratulations to this pioneering researcher!
